Harvard Apparatus Regenerative Technology, Inc. (NASDAQ: HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will hold a conference call to discuss recent events at 11:00 AM (Eastern Time) on December 23, 2014. On that call, management may take questions from the audience on any of a number of topics related to the business, including operations, plans and outlook.
Help employers find you! Check out all the jobs and post your resume.
